Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Wellness Center USA, Inc. (WCUI)
Tucson, AZ, US
Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. It operates through Medical Devices; and Authentication and Encryption Products and Services segments. The company is primarily involved in the marketing and distribution of online sports and nutrition supplements. It also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, the company offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -81.82% | -98.75% | -99.73% | -99.93% | -99.98% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Specialties: +8.3%+14.5% ★ Q3'22: +973.3% (vs Q3'21)
-
EPS growth Medical - Specialties: +10.1%+35.7% ★ Q3'22: +38.1% (vs Q3'21)
-
FCF margin FCF growth · Medical - Specialties: +51.3%-114.2% Q3'22: -62.6% (vs Q3'21)
-
EBIT margin Medical - Specialties: +12.6%-106.9% Q3'22: -126.9% (vs Q3'21)
-
ROIC Medical - Specialties: +6.6%— Q3'22: +139.6% (vs Q3'21)
-
Share dilution Medical - Specialties: 0.0%+6.8% Q3'22: +12.7% (vs Q3'21)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-5.72× Q3'22: -4.26× (vs Q3'21)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Calvin R. O’Harrow Living Trust | 5.61M | 8.40% | 5.61M | — | 5.61M | 10.00 | IN | Wisconsin | 2016-01-04 | ↗ |
| 2 | Calvin R. O’ Harrow Roth IRA | 117.0K | 0.10% | 117.0K | — | 117.0K | 10.00 | EP | Wisconsin | 2016-01-04 | ↗ |
Institutional Activity (13F)
Institutional history not available.
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ASSOCIATED BANC-CORP | — -12.5K (-100.0%) | — -6.0 (-100.0%) | 0.00% -0.009 pp | 0.00% +0.000 pp | USD— | 12 qtrs SOLD |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-05-01 | CALVIN R O'HARROW TTEE U/A DTD 2/12/2009 O'HARROW LIVING TRUST | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 866,667 | 0.18 | 156.0K | 10,344,443 | — | ↗ |
| 2016-04-13 | CALVIN R O'HARROW ROTH IRA | 10% Owner | P-Purchase | A | Common Stock | 124,806 | 0.18 | 22.5K | 500,000 | — | ↗ |
| 2016-04-12 | CALVIN R O'HARROW ROTH IRA | 10% Owner | P-Purchase | A | Common Stock | 207,500 | 0.17 | 35.2K | 375,194 | — | ↗ |
| 2016-04-11 | CALVIN R O'HARROW ROTH IRA | 10% Owner | P-Purchase | A | Common Stock | 167,694 | 0.16 | 27.3K | 167,694 | — | ↗ |
| 2016-04-01 | CALVIN R O'HARROW TTEE U/A DTD 2/12/2009 O'HARROW LIVING TRUST | 10% Owner | P-Purchase | A | Common Stock | 11,300 | 0.17 | 1.9K | 5,738,223 | — | ↗ |
| 2016-03-31 | CALVIN R O'HARROW TTEE U/A DTD 2/12/2009 O'HARROW LIVING TRUST | 10% Owner | P-Purchase | A | Common Stock | 88,700 | 0.15 | 13.3K | 5,726,923 | — | ↗ |
| 2016-03-30 | CALVIN R O'HARROW TTEE U/A DTD 2/12/2009 O'HARROW LIVING TRUST | 10% Owner | P-Purchase | A | Common Stock | 1,000 | 0.15 | 154.90 | 5,638,223 | — | ↗ |
| 2016-01-11 | CALVIN R O'HARROW TTEE U/A DTD 2/12/2009 O'HARROW LIVING TRUST | 10% Owner | P-Purchase | A | Common Stock | 32,000 | 0.21 | 6.7K | 5,637,223 | — | ↗ |
| 2016-01-11 | CALVIN R O'HARROW ROTH IRA | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-12-14 | CALVIN R O'HARROW TTEE U/A DTD 2/12/2009 O'HARROW LIVING TRUST | — | — | D | Common Stock | 0 | 0.00 | — | 5,605,223 | — | ↗ |
| 2015-12-14 | CALVIN R O'HARROW ROTH IRA | — | — | D | Common Stock | 0 | 0.00 | — | 117,000 | — | ↗ |
| 2015-03-02 | Kandalepas Andrew J | Director / Officer | G-Gift | D | Common Stock | 250,000 | 0.00 | — | 3,415,000 | — | ↗ |
| 2014-06-24 | JOSHI JAY | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 36,600 | 0.27 | 9.9K | 5,319,934 | — | ↗ |
| 2014-02-28 | JOSHI JAY | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 5,283,334 | — | ↗ |
| 2012-01-16 | Tsolinas Peter M | 10% Owner | G-Gift | D | Class A Common Stock | 200,000 | 0.00 | — | 1,482,500 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Calvin R. O'Harrow | Chief Executive Officer, Chief Operating Officer & Chairman | — | male |
| Douglas W. Samuelson | Chief Financial Officer & Chief Accounting Officer | — | male |
| Paul D. Jones | President & Director | — | male |
| Thomas E. Scott | Secretary & Director | — | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WCUI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
